Moreover, SHMT2 knockdown resulted in significant co-immunoprecipitation of β-catenin with K63 ubiquitin, suggesting that SHMT2 enhanced the BRCC36-mediated deubiquitination of β-catenin in CRC cells (Figure S5D). The gene discussed is BRCC3; the disease is colorectal carcinoma.